
InterCure Ltd Investor Relations Material
Latest events

Q4 2022
InterCure Ltd

Q4 2023
1 May, 2024

Q2 2023
31 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from InterCure Ltd
Access all reports
InterCure Ltd is a pharmaceutical company focused on the production and distribution of medical cannabis products. Through its subsidiary, Canndoc, the company cultivates and manufactures pharmaceutical-grade cannabis used for medical treatments. InterCure offers a range of cannabis-based products, including oils, flowers, and other formulations designed for therapeutic purposes. The company partners with international healthcare and cannabis companies to expand its product offerings and distribution channels in global markets where medical cannabis is regulated. The company is headquartered in Herzliya, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
INCR
Country
🇺🇸 United States